Other Information
−Removed: Exhibit Description
−Removed: Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.
−Removed: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: The following financial information from Modular Medical, Inc.’s
−Removed: quarterly report on Form 10-Q for the period ended September 30, 2023, filed with the SEC on November 13, 2023, formatted in Inline Extensible
−Removed: Business Reporting Language (Inline XBRL):
−Removed: (i) the Condensed Consolidated Statements of Operations for the three and six months ended
−Removed: September 30, 2023 and 2022, (ii) the Condensed Consolidated Balance Sheets as of September 30 2023 and March 31, 2023, (iii) the Condensed
−Removed: Consolidated Statements of Stockholders’ Equity for the three and six months ended September 30, 2023 and 2022, (iv) the Condensed
−Removed: Consolidated Statements of Cash Flows for the six months ended September 30, 2023 and 2022, and (v) Notes to Condensed Consolidated Financial
−Removed: Cover Page Interactive Data File (formatted as Inline
−Removed: XBRL and contained in Exhibit 101).
+Added: Agreement, dated as of November 22, 2023, between Modular Medical, Inc.
+Added: and Leerink Partners LLC
+Added: Medical, Inc.
+Added: Two-Part FDA Submission and Clearance Milestone Bonus Program
+Added: Certification
+Added: of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Certification
+Added: of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Certification
+Added: of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.
+Added: Section 1350, as adopted pursuant to Section
+Added: 906 of the Sarbanes-Oxley Act of 2002
+Added: XBRL Instance Document
+Added: Inline XBRL Taxonomy Extension Schema Document
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document
+Added: Inline XBRL Taxonomy Extension Label Linkbase Document
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
Pursuant to the requirements of the Securities Exchange Act
1 unchanged sentence
MODULAR MEDICAL, INC.
−Removed: November 13, 2023
+Added: February 13, 2024
Chief Executive Officer
(Principal Executive Officer)
−Removed: Chairman, President, Chief Financial Officer
−Removed: and Treasurer
+Added: Chairman, President, Chief Financial
(Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.